Metabolic pathways | Lipid mediator | Control | P. chabaudi | P. berghei |
---|---|---|---|---|
Arachidonic acid (AA) | 6-keto-PGF1α | 13.4 ± 7.9 | 43.9 ± 15.6 | 105.1 ± 77.6* |
TXB2 | 3.4 ± 1.7 | 12.1 ± 12.8 | 26.9 ± 23.3 | |
PGF2α | 7.9 ± 2.1 | 38.7 ± 19.5* | 38.7 ± 11.7* | |
PGD2 | 7.0 ± 0.6 | 53.2 ± 23.5* | 34.7 ± 6.6* | |
PGA2 | 2.4 ± 0.4 | 10.2 ± 6.4* | 5.8 ± 1.6 | |
12-HHT | 43.7 ± 5.9 | 145.1 ± 23.1* | 182.7 ± 70**, # | |
AA | 16,644 ± 4727.6 | 21,033.5 ± 9395.7 | 22,340.5 ± 6285.2 | |
Linoleic acid (LA) | 13-HODE | 911.6 ± 183.9 | 5724.6 ± 5486.6 | 1934.3 ± 989.8 |
9-HODE | 1159.2 ± 314.2 | 7427.6 ± 6820.3 | 2521.9 ± 1288.6 | |
Eicosapentaenoic acid (EPA) | 17,18-DiHETE | 11.5 ± 1.4 | 8.6 ± 5.9 | 9.2 ± 4.1 |
EPA | 4702.9 ± 954.4 | 1160 ± 292.7*** | 1483.4 ± 391.1*** | |
Docosahexaenoic acid (DHA) | 8-HDoHE | 136.8 ± 52.9 | 208.3 ± 85.6 | 221.9 ± 49.7 |
DHA | 73,814.6 ± 16,486.1 | 50,135.2 ± 9021.8* | 57,149.6 ± 8011.9 | |
α-Linolenic acid (ALA) | 9-HOTrE | 16.9 ± 1.2 | 121.4 ± 110.5 | 42.1 ± 13.8 |
Ethanolamide (EA) | AEA | 21.1 ± 2.2 | 6.4 ± 2.9*** | 9.9 ± 4.4*** |
OEA | 36.5 ± 10.5 | 62.9 ± 22.2 | 72.1 ± 25 | |
Ratio of AA/EPA |  | 3.6 ± 0.8 | 19.9 ± 11.9* | 16.7 ± 7.7 |